Robert H. Getzenberg
Advertisement
Articles by Robert H. Getzenberg
Advertisement
Latest Updated Articles
7 TiP Randomized, Multicenter, International Phase 3 ARTEST Study to Evaluate the Efficacy and Safety of Enobosarm Versus Active Control for the Treatment of AR+, ER+, HER2– Metastatic Breast Cancer in Patients Who Previously Received an Estrogen-Blocking Agent and CDK4/6 InhibitorPublished: April 18th 2022 | Updated:
- 8 TiP Randomized, Multicenter, Phase 3 Study to Evaluate the Combination of Enobosarm and Abemaciclib Compared With Estrogen-Blocking Agent for the Second-Line Treatment of AR+, ER+, HER2– Metastatic Breast Cancer in Patients Who Have Previously Received Palbociclib and an Estrogen-Blocking Agent Combination Therapy
Published: April 18th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Nurse-Led Telehealth Displays Feasibility in Ovarian Cancer Follow-Up
2
FDA Accepts New Drug Application for 177Lu-Edotreotide in GEP-NETs
3
Post-IO Curative Treatment Conversion May Prolong Survival in Liver Cancer
4
How do PDX and Computational Models Assist in the Development of ADCs?
5
